Gene testing and reporting for Ovarian cancer specimens
NHS Greater Glasgow and Clyde, Laboratory Genetics requires an end-to-end diagnostic service for FFPE block processing, DNA based Homologous Repair Deficiency (HRD) and BRCA1 and BRCA2 gene testing and reporting for Ovarian cancer specimens. This service is required for approximately 200 tests per annum and the service must be available by 1st December 2026.
Buyer
NHS Greater Glasgow and Clyde
Value
£363,000
Published
19 Nov 2026
Closes
Not provided
Procurement details
Source
Find a Tender
Region
UKM82
Procurement method
Limited
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
85145000
Services provided by medical laboratories
Lots
Lot 1 Gene testing and reporting for Ovarian cancer specimens
£363,000
NHS Greater Glasgow and Clyde requires an end-to-end diagnostic service for FFPE block processing, DNA based Homologous Repair Deficiency (HRD) and BRCA1 and BRCA2 gene testing and reporting for Ovarian cancer specimens. The technical processing and laboratory reporting must be validated to ISO 15189 (2022) standards or equivalent and the underlying technolo...
Delivery: UKM82
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.